v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows from Operating Activities:    
Net loss $ (41,052) $ (61,550)
Reconciliation of net loss to net cash used in operating activities:    
Depreciation and amortization 2,337 1,336
Amortization of debt discount 977 1,273
Change in fair value of derivatives (9,416) 1,328
Change in fair value of share payable (127) 381
Change in fair value of convertible notes (1,352) (6,074)
Loss from extinguishment of debt 9,980 15,802
Loss from issuance of debt 2,912 2,384
Inducement expense 534  
Non - cash financing cost 150  
Amortization of operating lease right-of-use asset 253 200
Stock-based compensation for services 617 1,022
Allowance for credit loss 325  
Subtotal of non-cash charges 7,190 17,652
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 437 (389)
Other non-current assets (22) 13
Accounts payable and accrued expenses 5,739 8,855
Related party accounts payable and accrued expenses (364) 5,389
Lease liabilities (364) 31
Net cash used in operating activities (28,436) (29,999)
Cash Flows from Investing Activities:    
Purchase of equipment and construction in progress (380) (599)
Loan receivable   (311)
Net cash used in investing activities (380) (910)
Cash Flows from Financing Activities:    
Proceeds from issuance of common shares 3,004 17,304
Proceeds from exercise of warrants 28 23
Proceeds from issuance of convertible notes payable, net 16,550 12,682
Proceeds from warrant modification 2  
Repayment of convertible notes payable (500) (1,011)
Payment to related party (1,673)  
Net cash provided by financing activities 25,211 35,739
Effect of exchange rate changes on cash and cash equivalents 1,290 (2,445)
Net (decrease) increase in cash and cash equivalents (2,315) 2,385
Cash and cash equivalents, beginning of the period 3,040 2,175
Cash and cash equivalents, end of the period 725 4,560
Supplemental schedule of non-cash activities:    
Issuance of common stock for conversion of debt and accrued interest 36,923 27,733
Series C convertible preferred stock conversions 2,312 2,107
Capital expenditures included in accounts payable 167 768
Deemed dividend related to warrant modifications 910 1,178
Reclassification between contingent payment obligation and convertible notes payable at fair value   3,000
Reclassification of liability classified warrants to equity   3,460
Right-of-use asset recognized in exchange for lease liability 967  
Non-Related party    
Cash Flows from Financing Activities:    
Proceeds from issuance of notes 7,000 7,000
Repayment of notes payable   (259)
Related party    
Cash Flows from Financing Activities:    
Proceeds from issuance of notes 1,030  
Repayment of notes payable (230)  
Notes payable    
Supplemental disclosure of cash flow information    
Interest payments (300) (122)
Convertible notes payable    
Supplemental disclosure of cash flow information    
Interest payments $ (39) $ (103)